Inhibition of Hepatitis B virus replication by the interferon-inducible MxA protein

Journal of Virology

Volumn 75, Issue 6, 2001, Pages 2684-2691

  Gordien, E ^a   Rosmorduc, O ^a   Peltekian, C ^a   Garreau, F ^a   Brechot C ^a   Kremsdorf, D ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MYXOVIRUS RESISTANCE PROTEIN A; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL SECRETION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CELL NUCLEUS; DNA, VIRAL; GTP-BINDING PROTEINS; HEPATITIS B VIRUS; HUMANS; INTERFERONS; NUCLEOCAPSID; NUCLEOCAPSID PROTEINS; PLASMIDS; PROTEINS; RNA, VIRAL; TRANSFECTION; TUMOR CELLS, CULTURED; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0035123448     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.6.2684-2691.2001     Document Type: Article

References (57)

1. Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression
2. Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5)
3. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication
4. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells
5. Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in hepatoma cell line
6. Genomic sequencing
7. Inhibition of hepatitis B virus in tissue culture by alpha interferon
8. Type 1 interferons
9. A preliminary trial of lamivudine for chronic hepatitis B infection
10. Impaired interferon induction of human MxA protein in chronic hepatitis B virus infection
11. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons and double-stranded RNA
12. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein
13. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus
14. High-level hepatitis B virus replication in transgenic mice
15. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts
16. Mx proteins: Mediators of innate resistance to RNA viruses
17. Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA
18. A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products
19. Role of the hepatitis B virus posttranslational regulatory element in export of intronless transcripts
20. Strong transient expression of the type 1 interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C
21. Effects of transforming growth factor-beta 1 against the inhibitory action of interferon on DNA synthesis and viral replication in hepatitis B virus DNA-transfected cell
22. Replication of hepatitis B virus
23. Impaired antiviral response in human hepatoma cells
24. GTP-bound human MxA protein interacts with the nucleocapsids of Thogoto virus (Orthomyxoviridae)
25. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids
26. Direct modulation of HBV surface antigen in a human. HBsAg-producing hepatocellular carcinoma cell line by alpha, beta, or gamma interferons
27. Hepatitis B virus core gene mutations which block nucleocapsid envelopment
28. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins
29. Hepatitis B virus replication
30. Defective response to interferon in cells transfected with the hepatitis B virus genome
31. Enhanced virus resistance of transgenic mice expressing the human MxA protein
32. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle
33. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein
34. A hepatitis B virus mutant with a new hepatocyte nuclear factor l binding site emerging in transplant-transmitted fulminant hepatitis B
35. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells
36. Cytokine inhibition of the hepatitis B virus core promoter
37. In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA
38. Inhibition of interferon-inducible MxA protein expression by hepatitis B virus capsid protein
39. Export of hepatitis B virus RNA on a Rev-like pathway: Inhibition by the regenerating liver inhibitory factor IκBα
40. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis
41. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame
42. New nucleoside analogues for chronic hepatitis B
43. Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells
44. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line
45. Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes
46. Vesicular stomatitis virus transcription inhibited by purified MxA protein
47. Hepatitis B virus biology
48. The hepatitis B virus post-transcriptional regulatory element contains two conserved RNA stem-loops which are required for function
49. Defective hepatitis B virus particles are generated by packaging and reverse transcription of spliced viral RNAs in vivo
50. Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity
51. Alpha interferon suppresses hepatitis B situs enhancer activity and reduces viral gene transcription
52. Transcription of the human beta interferon gene is inhibited by hepatitis B virus
53. Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene
54. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice
55. Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons
56. Identification of glyceraldehyde-3-phosphate dehydrogenase as a cellular protein that binds to the hepatitis B virus posttranscriptional regulatory element
57. Inhibition of human parainfluenza virus-3 replication by interferon and human MxA